Developmental Protein Plays Role in Spread of Cancer

A protein used by embryo cells during early development, and recently found in many different types of cancer, apparently serves as a switch regulating the spread of cancer, known as metastasis, report researchers at the University of California, San Diego School of Medicine and UC San Diego Moores Cancer Center in the June 15, 2013 issue of the journal Cancer Research.

Metastasis is responsible for 90 percent of cancer-related deaths. More than 575,000 Americans die of cancer each year, the second leading cause of death in the United States after cardiovascular disease.

The scientists, led by principal investigator Thomas Kipps, MD, PhD, Evelyn and Edwin Tasch Chair in Cancer Research at UC San Diego, discovered an association between the protein, called Receptor-tyrosine-kinase-like Orphan Receptor 1 or ROR1, and the epithelial-mesenchymal transition (EMT), a process that occurs during embryogenesis when cells migrate and then grow into new organs during early development.

In research published in 2012, Kipps and colleagues reported for the first time that ROR1 is expressed during embryogenesis and by many different types of cancers, but not by normal post-partum tissues. They also discovered that silencing the protein impaired the growth and survival of human breast cancer cells.

In their latest work, the scientists found that high-level expression of ROR1 in breast cancer cells correlates to higher rates of relapse and metastasis in patients with breast adenocarcinoma, a type of cancer that originates in glandular tissue. Conversely, silencing expression of ROR1 reverses EMT and inhibits the metastatic spread of breast cancer cells in animal models. Moreover, the researchers found that treatment with a monoclonal antibody targeting ROR1 also could inhibit the growth and spread of highly metastatic tumors that express ROR1.

We might think of ROR1 as an oncogene, said study co-author Bing Cui, PhD, a postdoctoral fellow in Kipps lab. This means ROR1 has some tumor initiation functions. However, ROR1 also appears to allow transformed cells to invade other tissues and to promote tumor expansion in both the primary tumor site and in distant organs.

Because ROR1 is expressed only in cancer cells, Kipps team says it presents a singular, selective target for anti-cancer therapies that would leave normal cells unaffected. Its not yet clear how the monoclonal antibody approach, tested thus far only in culture and animal models, impacts primary tumors, said Cui, but it does offer promise for inhibiting the spread of cancer. The researchers are developing a humanized monoclonal antibody for potential clinical studies in patients with cancers that express ROR1.

Co-authors are Suping Zhang, Liguang Chen, Jianqiang Yu, George F. Widhopf II, Jessie F. Fecteau and Laura Z. Rassenti, all of UC San Diego Moores Cancer Center and the Department of Medicine, UCSD.

Funding for this research came, in part, from the National Institutes of Health (grant PO1-CA081534), the California Institute of Regenerative Medicine and the Blood Cancer Research Fund, UC San Diego Foundation.

More information you can also find on website: Lung Cancer

News source: NewsWise

Source:
Developmental Protein Plays Role in Spread of Cancer

See also:

Junk Removal in Houston - Not being part of a franchise means competitive pricing.
Junk Services Houston, a junk removal co., was built on the foundation of honesty, the original American way of doing business. When you call them you wont get a press 1 for this, or 2 for that, you...

OMICS GROUP announces acquisition of Journal of Molecular and Genetic Medicine from LibPubMedia
With great pride and honor, OMICS Group Inc. is pleased to announce the acquisition of Journal of Molecular and Genetic Medicine (JMGM) to its more than 300 journals collection, building headstrong...

Opportunity & Risk: Uncovering and Winning the Distressed Deal
Download the Complimentary Report here: http://bit.ly/11oNfvXMerrill DataSite is pleased to present the latest complimentary chapter of our popular M&A series, which discusses best practices for...

Interesting links:

Best art today source. Please visit and share.